Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Rocky Mountain Cancer Centers
With
University of Colorado, Denver
Age
18–65
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Age 18-65 years
Presence of malignancy or hematological disease whose treatment will be allogeneic stem cell transplant and high-dose conditioning therapy.
Adequate baseline evaluation: adequate renal function (creatinine clearance \> 60 ml/min); Adequate hepatic function (SGOT, SGPT, bilirubin and alkaline phosphatase \< 1.5 times normal); adequate cardiac function (MUGA showing a left ventricular ejection at rest \> 45%); adequate pulmonary function (DCLO \> 60%).
You may not be if
Known hypersensitivity to ANP or mannitol
Congestive heart failure
Previous bone marrow transplant
BP less than 90 mm systolic or less than 60 mm Hg diastolic
Clareo Health | Prevention Of Nephrotoxicity Following Bone Marrow Transplantation Using Urodilatin and Mannitol
